Central sympathetic nervous system
Showing 26 - 50 of >10,000
Seen on Brain Imaging in Pediatric Patients Following Proton
Recruiting
- Malignant Central Nervous System Neoplasm
- Malignant Skull Base Neoplasm
- Medical Chart Review
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 6, 2023
Vasoconstriction, Healthy, Insulin Resistance Trial in Columbia (Insulin)
Active, not recruiting
- Vasoconstriction
- +2 more
-
Columbia, MissouriUniversity of Missouri
Feb 7, 2022
Central Nervous System Metastatic EGFR Mutation Positive NSCLC
Not yet recruiting
- NSCLC
-
Changsha, Hunan, ChinaHunan Cancer hospital
Aug 6, 2023
Primary CNS Lymphoma, Secondary CNS Lymphoma, Relapsed Cancer Trial in Miami (drug, procedure, radiation)
Not yet recruiting
- Primary Central Nervous System Lymphoma
- +3 more
- Pemetrexed
- +3 more
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Dec 23, 2022
Primary CNS Lymphoma, Secondary CNS Lymphoma Trial in Beijing (GNC-038)
Recruiting
- Primary Central Nervous System Lymphoma
- Secondary Central Nervous System Lymphoma
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital, Capital Medical University
Jul 31, 2022
CNS Effects of Diphenhydramine, Pharmacokinetics of Diphenhydramine Trial in Amherst (DiphenhydrAMINE Injectable Solution)
Terminated
- Central Nervous System Effects of Diphenhydramine
- Pharmacokinetics of Diphenhydramine
- DiphenhydrAMINE Injectable Solution
-
Amherst, New YorkDent Neurologic Institute
Oct 4, 2022
Primary CNS Lymphoma and Primary Vitreoretinal Lymphoma Trial (intensity-modulated radiotherapy (IMRT))
Not yet recruiting
- Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma
- intensity-modulated radiotherapy (IMRT)
- (no location specified)
Jun 4, 2023
Refractory CNS Lymphoma, Relapsed Primary CNS Lymphoma, Primary CNS Lymphoma Trial in Hangzhou (Nivolumab)
Active, not recruiting
- Refractory Central Nervous System Lymphoma
- +2 more
-
Hangzhou, Zhejiang, ChinaJianmin Zhang
Jul 3, 2022
Medulloblastoma, CNS Tumor, Pediatric, Ependymoma Trial in Beijing
Recruiting
- Medulloblastoma
- +5 more
-
Beijing, Beijing, ChinaBeijing Tiantan Hosiptal
Jan 3, 2023
Primary CNS Lymphoma Trial in Hangzhou (Rituximab, Lenalidomide, Methotrexate)
Completed
- Primary Central Nervous System Lymphoma
- Rituximab
- +2 more
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Nov 18, 2022
Primary CNS Lymphoma Trial in Hanzhou (Orelabrutinib, Rituximab, Methotrexate)
Recruiting
- Primary Central Nervous System Lymphoma
- Orelabrutinib
- +2 more
-
Hanzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Nov 3, 2022
Metabolic Syndrome, Type 2 Diabetes, Obesity Trial in Perth (Empagliflozin Oral Tablet [Jardiance], Placebo Oral Tablet)
Recruiting
- Metabolic Syndrome
- +2 more
- Empagliflozin Oral Tablet [Jardiance]
- Placebo Oral Tablet
-
Perth, Western Australia, AustraliaRoyal Perth Hospital
Sep 23, 2021
Central Nervous System Following Spinal Cord Injury
Recruiting
- Spinal Cord Injuries
- +2 more
-
Zurich, SwitzerlandBalgrist University Hospital
Jan 11, 2023
Clinical Significance of Occult Central Nervous System
Recruiting
- Acute Lymphoblastic Leukemia
- cerebrospinal fluids exams
-
Roma, RM, ItalyTor Vergata University
Mar 17, 2023
Spontaneous Coronary Artery Dissection, Healthy Trial in Rochester (Arterial Tonometry, Echocardiogram, Carotid Ultrasounds)
Not yet recruiting
- Spontaneous Coronary Artery Dissection
- Healthy
- Arterial Tonometry
- +5 more
-
Rochester, MinnesotaMayo Clinic Rochester
Jan 16, 2023
B-cell Acute Lymphocytic Leukemia Trial in Suzhou (CD19 CAR-T cells)
Recruiting
- B-cell Acute Lymphocytic Leukemia
- CD19 CAR-T cells
-
Suzhou, ChinaThe First Affiliated Hospital of Soochow University
Jan 11, 2023
CNS Lymphoma, Secondary CNS Lymphoma Trial run by the National Cancer Institute (NCI) (TEDD-R, TEDDI-R, Ibrutinib)
Recruiting
- Central Nervous System Lymphoma
- Secondary Central Nervous System Lymphoma
- TEDD-R
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
New High Resolution Ultrasonographic Modalities for Diagnosis of
Not yet recruiting
- Ultrasound Therapy; Complications
- +2 more
- High-resolution ultrasonography
-
Assiut, EgyptWoman's Health University Hospital
Mar 18, 2023
Cognitive Impairment in Non-central Nervous System Cancer
Not yet recruiting
- Breast Cancer
- +2 more
- Saint-Louis Lille Battery (SSLIB)
- (no location specified)
Mar 6, 2023
Radiation Therapy in Pediatric Central Nervous System Tumors
Completed
- Diffuse Intrinsic Pontine Glioma
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Implication of New High Resolution Ultrasonographic Modalities
Recruiting
- Ultrasound Therapy; Complications Anomaly Central Nervous System Diseases
- High-resolution ultrasonography
-
Assiut, EgyptWoman's Health University Hospital
Mar 5, 2023
HLH Trial in Beijing (Thiotepa)
Recruiting
- HLH
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
May 10, 2023
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the CNS
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Dabrafenib
- MEK-1/MEKK-1 Inhibitor E6201
-
Scottsdale, Arizona
- +2 more
Jan 4, 2023
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)
Not yet recruiting
- Diffuse Intrinsic Pontine Glioma
- +4 more
- SC-CAR4BRAIN
-
Seattle, WashingtonSeattle Children's Hospital
Mar 3, 2023